Stem Cells in Neurodegenerative Diseases

Stem cells have the potential to develop into many different types of cells in the body and may be useful as a therapy for several diseases including neurodegenerative diseases. Discover the latest research on stem cells and neurodegenerative diseases here.

April 17, 2021

Targeting Adenosine Receptors in Neurological Diseases.

Cellular Reprogramming
Muhmmad AtifQaisar Raza
April 16, 2021
Preprint
Open Access

The Alzheimer's disease risk factor APOE4 drives pro-inflammation in human astrocytes via HDAC-dependent repression of TAGLN3

BioRxiv : the Preprint Server for Biology
L. ArnaudEmmanuel Nivet
April 17, 2021

Oxidative Stress Sensing and Response in Neural Stem Cell Fate.

Free Radical Biology & Medicine
Inah HwangJihye Paik
April 16, 2021

Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling.

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Sebastian PetersUlrich Bogdahn
April 16, 2021
Comment / Editorial
Open Access

Editorial: The Use of Biomaterials With Stem and Precursor Cells in Diseases of the Central Nervous System; A Step to Clinical Trials.

Frontiers in Neurology
Rodrigo Ramos-ZúñigaJorge Matias-Guiu
April 16, 2021
Review
Open Access

GM1 Gangliosidosis: Mechanisms and Management.

The Application of Clinical Genetics
Allisandra K RhaDouglas R Martin
April 16, 2021
Open Access

A stress-free strategy to correct point mutations in patient iPS cells.

Stem Cell Research
Jingli CaiLorraine Iacovitti
April 16, 2021

Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN.

Neurobiology of Disease
Masahiro NogamiHideyuki Okano
April 16, 2021

A Helicase Unwinds Hexanucleotide Repeat RNA G-Quadruplexes and Facilitates Repeat-Associated Non-AUG Translation.

Journal of the American Chemical Society
Honghe LiuJiou Wang
April 16, 2021
Review
Open Access

Mesenchymal Stem Cells for Neurological Disorders.

Advanced Science
Anna AndrzejewskaMiroslaw Janowski
April 16, 2021
Open Access

Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models.

Journal of Tissue Engineering
Ha Na KimPhil Hyu Lee
April 14, 2021
Preprint
Open Access

FAN1 nuclease activity affects CAG expansion and age at onset of Huntington's disease

BioRxiv : the Preprint Server for Biology
B. H. McAllisterThomas H Massey
April 14, 2021
Review

Clinical applications of dental stem cells in modern regenerative medicine: A systematic review with updates.

Nigerian Journal of Clinical Practice
T Y Alhazzazi, F T Alghamdi
April 14, 2021

Control the Neural Stem Cell Fate with Biohybrid Piezoelectrical Magnetite Micromotors.

Nano Letters
Lu LiuFei Peng
April 13, 2021

Age-Related Macular Degeneration: From Epigenetics to Therapeutic Implications.

Advances in Experimental Medicine and Biology
Michael H Farkas, Margaret M DeAngelis

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved
/feed-previews/stem-cells-in-neurodegenerative/eb7df63c-93a6-4753-a40e-b95572ef94b2